Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $12,331 - $13,721
-59 Reduced 1.18%
4,948 $1.08 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $1,186 - $1,363
6 Added 0.12%
5,007 $1.14 Million
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $1,809 - $1,995
-9 Reduced 0.18%
5,001 $1.01 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $26,703 - $30,407
-126 Reduced 2.45%
5,010 $1.21 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $7,252 - $8,766
34 Added 0.67%
5,136 $1.18 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $15,686 - $19,170
-77 Reduced 1.49%
5,102 $1.2 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $7,987 - $10,225
39 Added 0.76%
5,179 $1.06 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $4,277 - $5,557
-20 Reduced 0.39%
5,140 $1.21 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $271 - $314
1 Added 0.02%
5,160 $1.62 Million
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $34,352 - $38,542
125 Added 2.48%
5,159 $1.45 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $28,461 - $31,429
113 Added 2.3%
5,034 $1.39 Million
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $17,005 - $21,167
83 Added 1.72%
4,921 $1.26 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $5,607 - $6,432
30 Added 0.62%
4,838 $985,000
Q3 2020

Nov 16, 2020

SELL
$167.03 - $201.3 $67,146 - $80,922
-402 Reduced 7.72%
4,808 $905,000
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $7,705 - $12,405
68 Added 1.32%
5,210 $865,000
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $98,060 - $183,563
-940 Reduced 15.46%
5,142 $650,000
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $5,721 - $6,076
35 Added 0.58%
6,082 $1.03 Million
Q3 2019

Nov 14, 2019

BUY
$159.77 - $178.1 $3,994 - $4,452
25 Added 0.42%
6,047 $1.02 Million
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $2,883 - $3,458
-20 Reduced 0.33%
6,022 $1.04 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $6,185 - $7,815
50 Added 0.83%
6,042 $924,000
Q4 2018

Feb 14, 2019

BUY
$120.82 - $174.09 $4,228 - $6,093
35 Added 0.59%
5,992 $757,000
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $22,803 - $25,604
136 Added 2.34%
5,957 $1.04 Million
Q2 2018

Aug 15, 2018

SELL
$160.33 - $189.41 $464,155 - $548,341
-2,895 Reduced 33.21%
5,821 $1.05 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $418,461 - $494,360
2,610 Added 42.74%
8,716 $1.24 Million
Q1 2018

May 15, 2018

SELL
$161.53 - $178.11 $130,031 - $143,378
-805 Reduced 11.65%
6,106 $988,000
Q4 2017

Feb 12, 2018

SELL
$147.99 - $163.95 $96,341 - $106,731
-651 Reduced 8.61%
6,911 $1.1 Million
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $1.13 Million - $1.21 Million
7,562
7,562 $1.14 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track East Coast Asset Management, Llc. Portfolio

Follow East Coast Asset Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of East Coast Asset Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on East Coast Asset Management, Llc. with notifications on news.